Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.

NCT01148979 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Lisdexamfetamine Dimesylate (Vyvanse)
DRUG: Placebo

Sponsor

Mclean Hospital

Collaborators

[object Object]